Suramin: an anticancer drug with unique biological effects.
Department of Molecular Pharmacology, INSERM U 140, CNRS URA 147, Institut Gustave Roussy, Villejuif, France.
A K
AK
Larsen
D000818:Animals; D000970:Antineoplastic Agents / Q000494:pharmacology*; D002448:Cell Adhesion / Q000187:drug effects; D002454:Cell Differentiation / Q000187:drug effects; D002465:Cell Movement / Q000187:drug effects; D002467:Cell Nucleus / Q000201:enzymology; D006133:Growth Substances / Q000378:metabolism; D006801:Humans; D016623:Ion Pumps / Q000187:drug effects; D009687:Nuclear Proteins / Q000037:antagonists & inhibitors; D015388:Organelles / Q000187:drug effects / Q000378:metabolism; D015398:Signal Transduction / Q000187:drug effects; D013498:Suramin / Q000494:pharmacology*; D014407:Tumor Cells, Cultured
D000970:Antineoplastic Agents; D006133:Growth Substances; D016623:Ion Pumps; D009687:Nuclear Proteins; D013498:Suramin